News
News
![Les jeunes de l’IHM seront à l’EASD](https://institut-diabete.u-paris.fr/wp-content/uploads/sites/31/2024/07/EASDmadrid.jpg)
Les jeunes de l’IHM seront à l’EASD
L’IHM Diabète est heureux d’aider les jeunes à participer à l’EASD en leur attribuant une bourse de 1000€
Rendez-vous en Septembre à Madrid !
![Save the date : Journée Scientifique IHM Diabète le 14 Octobre 2024 9h-17h](https://institut-diabete.u-paris.fr/wp-content/uploads/sites/31/2023/05/savethedate.png)
Save the date : Journée Scientifique IHM Diabète le 14 Octobre 2024 9h-17h
Mark your calendars for October 14, when IHM Diabetes invites you to an exceptional scientific day.
![Congrès de la SFD 2024](https://institut-diabete.u-paris.fr/wp-content/uploads/sites/31/2023/11/SFD-2024.png)
Congrès de la SFD 2024
Pour profitez au maximum du congrès 2024, retrouvez les replays en ligne
![Early Registration before 17 July EASD 2024](https://institut-diabete.u-paris.fr/wp-content/uploads/sites/31/2023/11/EASD-2024-1080x643.png)
Early Registration before 17 July EASD 2024
Detailled information on the registration process and access to the registration system will be available in early 2024.
![A new article from Cécile Haumaitre and collaborators discusses the origin of pancreatic lesions associated with pancreatic cancer](https://institut-diabete.u-paris.fr/wp-content/uploads/sites/31/2023/12/article-Haumaitre-e1703147057864.png)
A new article from Cécile Haumaitre and collaborators discusses the origin of pancreatic lesions associated with pancreatic cancer
Pancreatic ductal adenocarcinoma is currently the fourth leading cause of cancer death worldwide. It is projected to become the second leading cause of cancer death by 2030. Unfortunately, PDAC is often diagnosed at an advanced stage, resulting in a 5-year survival rate of less than 10%. Since the most common precancerous lesions of PDAC are currently not clinically detectable, understanding the mechanisms that lead to their formation and progression is crucial to enabling early diagnosis and more effective therapeutic intervention.
![Journée Thématique SFD](https://institut-diabete.u-paris.fr/wp-content/uploads/sites/31/2023/11/Jornee-thematique.jpg)
Journée Thématique SFD
la Journée Thématique de la SFD aura lieu cette année le 15 décembre 2023 à l’Institut Pasteur de Paris, et sera consacrée au sujet «Diabète, îlots et Insulino-Sécrétion».
![Journée Scientifique conjointe Institut du Diabète et Graduate School METOD](https://institut-diabete.u-paris.fr/wp-content/uploads/sites/31/2023/11/join2-1080x675.png)
Journée Scientifique conjointe Institut du Diabète et Graduate School METOD
Keynotes of Stefan Trapp (University College London) and Marc Donath (University of Basel)
![Discovery of new rare genetic forms of obesity](https://institut-diabete.u-paris.fr/wp-content/uploads/sites/31/2023/11/jockers2.png)
Discovery of new rare genetic forms of obesity
This study, from Ralf Jockers and Julie Dam’s team as part of a European network for the prevention of childhood obesity, OBELISK,defines impaired GLP1R cell surface expression as a risk factor for traits associated with type 2 diabetes and obesity and provides potential treatment options for GLP1R LoF variant carriers.